GHK-Cu before and after

GHK-Cu is two products wearing one name. The cream has controlled human data behind it, and the injectable vial has none at all. Nearly every before-and-after claim online quietly borrows the first to sell the second.

Two routes, two literatures

GHK is a three-amino-acid peptide, glycyl-L-histidyl-L-lysine, discovered in human plasma in 1973. The copper complex sold as GHK-Cu is the same tripeptide carrying a copper ion, which is where the blue color comes from.

Plasma GHK falls with age. Pickart and Margolina put the level at about 200 ng/mL at age 20 and around 80 ng/mL by 60. That decline is the origin of every replacement argument made for the molecule, on either route.

What follows from it splits cleanly. Applied to skin, GHK-Cu has been tested in controlled cosmetic studies for four decades. Injected, it has been tested in mice. Nothing about the peptide changes between those two sentences; everything about the evidence does.

What the topical studies measured

The cosmetic literature is small-trial work with graded, instrument-assisted endpoints rather than photography. The most-cited study applied a GHK-Cu facial cream for 12 weeks to 71 women with mild to advanced photoaging. It reported increased skin density and thickness, reduced laxity, improved clarity, and reduced fine lines and wrinkle depth.

A companion eye cream study ran the same 12 weeks in 41 women and outperformed both placebo and a vitamin K cream. In a third, GHK-Cu applied to thigh skin improved collagen production in 70% of treated women, against 50% for a vitamin C cream and 40% for retinoic acid.

Three caveats belong in the same breath. These are cosmetic endpoints, not medical ones. Several were presented at dermatology meetings rather than published as full papers, so you can't inspect the methods the way you could a journal article's.

The review summarizing them is also written by the peptide's discoverer, who has a commercial research line in it. So the data is real, the effect sizes are modest, and the reporting sits closer to industry than to independent replication.

GHK-Cu

Copper tripeptide3 aaLyophilized

The copper-bound tripeptide discussed here, supplied as research-use-only material with a batch-matched certificate of analysis.

Shop GHK-Cu

Why the molecule barely gets in

Size is not the problem. The free tripeptide is 340 Da and the copper complex about 403 Da, both comfortably under the 500-dalton ceiling below which compounds are generally able to cross intact skin.

Water-loving chemistry is the problem. The stratum corneum is a lipid barrier, and GHK-Cu is hydrophilic, so it sits on the outside of a wall it is small enough to pass.

That's why modern formulation work is mostly about carriers. A 2023 study encapsulated GHK-Cu in lecithin liposomes and reached encapsulation efficiencies of 31.7% and 20.0% for cationic and anionic versions. The loaded peptide inhibited elastase by 48.9% in a dish.

Copper itself does cross human skin under occlusive application. What's unresolved is how much intact peptide arrives, in what state, and whether the cream you bought delivers any of it.

Injectable GHK-Cu: what actually exists

The injectable literature is preclinical, and it is not about skin.

• Colitis in mice. A 2025 study reported GHK-Cu attenuating ulcerative colitis through SIRT1/STAT3 signaling — a systemic anti-inflammatory model, not a cosmetic one.
• Wound hydrogels. GHK peptide nanofibers and copper-tripeptide hydrogels improve healing in animal wound models, delivered into the wound rather than into the bloodstream.
• Hair follicles in vitro. A tripeptide-copper complex increased human hair growth in culture. Culture is not a scalp.

Our route comparison lays the two evidence bases side by side. The asymmetry is not subtle, and it runs the opposite way to how the two forms are priced.

What the photos are actually showing

Skin photography is unusually easy to move without moving the skin.

• Light and angle. Fine lines and skin clarity are largely artifacts of lighting direction. The controlled studies used standardized capture and graded scales for exactly this reason.
• Everything else in the routine. Retinoids, vitamin C, sunscreen, acids and hydration all move the same endpoints, and most people start several at once.
• The 12-week window. Skin that is being looked after improves over three months regardless of which active gets the credit.
• Selection. The photo pair that gets posted is the one that worked.

Nothing here says GHK-Cu does nothing. The topical data is among the better evidence bases in cosmetic dermatology, which is a real if modest compliment. It says a photograph cannot distinguish a peptide from a routine, and the studies were designed specifically to do what a photograph cannot.

How to read a GHK-Cu before-and-after

Three questions, in order of how much they change the answer.

• Which route? If the claim is cosmetic and the product is a vial, the evidence being invoked belongs to a cream.
• Measured how? Skin density, thickness, wrinkle depth and collagen production are gradeable. A phone camera is not an endpoint.
• Against what? The useful comparisons in this literature are against placebo, vitamin C and retinoic acid — and against those, GHK-Cu is competitive, not transformative.

For the underlying biology, see our collagen mechanism write-up and the skin-aging evidence review. For what the literature does and does not support on dosing, our dosage page reports the published protocols and stops where they stop.

GHK-Cu

Batch-matched COAHPLC + mass specResearch use only

Research-use-only material, sold by the vial with batch documentation. Check the certificate of analysis against the batch you receive.

Learn more

Frequently asked questions